NKTCL patients can undergo PD-L1 mutation and TCR sequence analysis before receiving immune checkpoint inhibitor therapy to avoid excessive financial burden and reduce adverse events [127]. Here, CD274 is linked to extranodal nasal NK/T cell lymphoma.